Xenon Pharmaceuticals (XENE) Preferred Shares (2013 - 2021)
Xenon Pharmaceuticals (XENE) posted quarterly Preferred Shares of $7.7 million for Q4 2021, little changed year-over-year from $7.7 million in Q4 2020, and little changed quarter-over-quarter from $7.7 million in Q3 2021.
Xenon Pharmaceuticals (XENE) Preferred Shares (2013 - 2021) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Preferred Shares for 6 consecutive years, with $7.7 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Preferred Shares changed 0.0% year-over-year to $7.7 million; the TTM figure through Dec 2021 stood at $7.7 million (changed 0.0% YoY), while the FY2021 annual figure was $7.7 million, changed 0.0% from the prior year.
- Preferred Shares held at $7.7 million in Q4 2021 per XENE's latest filing, from $7.7 million in the prior quarter.
- Across five years, Preferred Shares topped out at $21.8 million in Q1 2018 and bottomed at $7.7 million in Q4 2018.
- Historically, Preferred Shares has averaged $9.8 million across 4 years, with a median of $7.7 million in 2018.
- On a YoY basis, Preferred Shares climbed as much as 0.0% in 2019 and fell as far as 64.57% in 2019.
- Xenon Pharmaceuticals' Preferred Shares stood at $7.7 million in 2018, then changed by 0.0% to $7.7 million in 2019, then changed by 0.0% to $7.7 million in 2020, then changed by 0.0% to $7.7 million in 2021.
- Business Quant data shows XENE's Preferred Shares at $7.7 million in Q4 2021, $7.7 million in Q3 2021, and $7.7 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 7.73 Mn |
| Sep 30, 2021 | 7.73 Mn |
| Jun 30, 2021 | 7.73 Mn |
| Mar 31, 2021 | 7.73 Mn |
| Dec 31, 2020 | 7.73 Mn |
| Sep 30, 2020 | 7.73 Mn |
| Jun 30, 2020 | 7.73 Mn |
| Mar 31, 2020 | 7.73 Mn |
| Dec 31, 2019 | 7.73 Mn |
| Sep 30, 2019 | 7.73 Mn |
| Jun 30, 2019 | 7.73 Mn |
| Mar 31, 2019 | 7.73 Mn |
| Dec 31, 2018 | 7.73 Mn |
| Sep 30, 2018 | 11.93 Mn |
| Jun 30, 2018 | 21.83 Mn |
| Mar 31, 2018 | 21.83 Mn |
| Sep 30, 2014 | 102.49 Mn |
| Dec 31, 2013 | 102.49 Mn |